Last reviewed · How we verify
NCT03509727
Procalcitonin in Diagnosis of Bacterial Infections in Young Infants
trial in Sepsis in 126 participants. Completed in 1 January 2018.
1 January 2018
Quick facts
| Lead sponsor | Belfast Health and Social Care Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 126 |
| Start date | 1 August 2017 |
| Primary completion | 1 January 2018 |
| Estimated completion | 1 January 2018 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Sepsis — all drugs for Sepsis →
Sponsor
Belfast Health and Social Care Trust — full company profile →
Who can join
Under 90 Days, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A diagnostic accuracy study investigating the accuracy of procalcitonin in diagnosing invasive bacterial infections in your infants.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study.
Waterfield T, Maney JA, Hanna M, Fairley D, et al · · 2018 · cited 13× · PMID 30541505 · DOI 10.1186/s12887-018-1349-7
Verify or expand the search:
- PubMed search for NCT03509727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sepsis
Currently open trials in the same condition.
- NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
- NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
Other Belfast Health and Social Care Trust trials
Trials by the same sponsor.
- NCT06985706 — Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser f · Phase 3 · recruiting
- NCT06626984 — Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis · Phase 1, PHASE2 · not yet recruiting
- NCT05414370 — Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model · NA · unknown
- NCT05431491 — Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients · NA · completed
- NCT06036225 — PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing. · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03509727 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Belfast Health and Social Care Trust
- Last refreshed: 26 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03509727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing